Cornerstone Capital Management Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-11,724
| Closed | -$464K | – | 1459 |
|
|
2016
Q1 | $464K | Sell |
11,724
-2,100
| -15% | -$83.1K | ﹤0.01% | 1053 |
|
|
2015
Q4 | $782K | Buy |
13,824
+424
| +3% | +$24K | 0.01% | 949 |
|
|
2015
Q3 | $534K | Sell |
13,400
-2,400
| -15% | -$95.6K | 0.01% | 996 |
|
|
2015
Q2 | $755K | Buy |
15,800
+5,200
| +49% | +$248K | 0.01% | 924 |
|
|
2015
Q1 | $421K | Buy |
10,600
+4,200
| +66% | +$167K | ﹤0.01% | 1058 |
|
|
2014
Q4 | $143K | Buy |
6,400
+3,400
| +113% | +$76K | ﹤0.01% | 1127 |
|
|
2014
Q3 | $47K | Buy |
+3,000
| New | +$47K | ﹤0.01% | 1220 |
|